# FDA Inspection 1166461 - Faxton St. Lukes Healthcare IRB - February 23, 2022

Source: https://www.keypedia.com/records/fda_inspections/faxton-st-lukes-healthcare-irb/c5eb9b71-634c-48e6-8530-5c8c010f1ba5
Source feed: FDA_Inspections

> FDA Inspection 1166461 for Faxton St. Lukes Healthcare IRB on February 23, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166461
- Company Name: Faxton St. Lukes Healthcare IRB
- Inspection Date: 2022-02-23
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs

## Related Documents

- [FDA Inspection 1166461 - 2022-02-23](https://www.keypedia.com/records/fda_inspections/faxton-st-lukes-healthcare-irb/a88b007e-a9bf-4401-91d2-34f3a13f89e1)
- [FDA Inspection 886543 - 2014-06-27](https://www.keypedia.com/records/fda_inspections/faxton-st-lukes-healthcare-irb/d0b14547-5614-4961-9631-95f9d4a6bd02)

Company: https://www.keypedia.com/companies/faxton-st-lukes-healthcare-irb/5c3bf921-c3d1-4e8e-a3ff-42e4f57b378b
